跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REXICALE Calcium Carbonate 625mg Tablets - NPRA Drug Approval Details
Approvals
/
NPRA
/
REXICALE Calcium Carbonate 625mg Tablets
Approved
STANDARD
REXICALE Calcium Carbonate 625mg Tablets
KCK PHARMACEUTICAL INDUSTRIES SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Jul 2, 2026
Approval ID
f6e7fa667524d1b4
Company
KCK PHARMACEUTICAL INDUSTRIES SDN. BHD.
Type
Standard
Approval Details
Approval Id
f6e7fa667524d1b4
Drug Approval Npra Name
REXICALE Calcium Carbonate 625mg Tablets
Product Name
REXICALE Calcium Carbonate 625mg Tablets
Registration Number
MAL26066097NE
Holder Company Name
KCK PHARMACEUTICAL INDUSTRIES SDN. BHD.
Holder Address
PLOT 61, BAYAN LEPAS INDUSTRIAL PARK PHASE 4, LINTANG BAYAN LEPAS 1, 11900 BAYAN LEPAS MALAYSIA
Holder Phone
04-6440766
Manufacturer Company Name
KCK PHARMACEUTICAL INDUSTRIES SDN. BHD.
Manufacturer Address
PLOT 61, BAYAN LEPAS INDUSTRIAL PARK PHASE 4 LINTANG BAYAN LEPAS 1 11900 BAYAN LEPAS MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL26066097NE
Version
1783019550
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Jul 2, 2026
Approval ID
f6e7fa667524d1b4
Type
Standard
Source
Official Source
Back to NPRA Approvals